Skip to main content

Table 2 Univariate analysis of the treatments and outcomes of patients with CTXNS-En and CTXS-En bacteremia

From: Clinical and microbiologic characteristics of cefotaxime-non-susceptible Enterobacteriaceae bacteremia: a case control study

Characteristics

CTXNS-Ena

(n = 37)

CTXS-En

(n = 74)

P-value

Empirical therapy

 Third-generation cephalosporins

5 (14%)

20 (27%)

0.15

 Other cephems

10 (27%)

21 (28%)

1.00

 β-lactam/β-lactamase inhibitors

11 (30%)

15 (20%)

0.34

 Carbapenems

10 (27%)

16 (22%)

0.64

 Other antibioticsb

0 (0%)

2 (3%)

1.00

 Appropriate empirical therapy

23 (62%)

66 (89%)

<0.01

 Complete response at 72 h

4 (11%)

23 (31%)

0.02

 Complete response at 7 days

23 (62%)

59 (80%)

0.07

 30-day mortality

2 (5%)

2 (3%)

0.60

  1. aOne patient died before antibiotics could be administered
  2. bOther antibiotics included amikacin (n = 1) and levofloxacin (n = 1)